dsm-firmenich Share Repurchase Program Progress
Analysis based on 10 articles · First reported Jun 02, 2026 · Last updated Jun 30, 2026
The share repurchase program by DSM-Firmenich is generally viewed positively by the market as it reduces the number of outstanding shares, potentially increasing earnings per share and stock value. This action directly impacts the stock price of DSM-Firmenich and signals confidence from the company's management.
DSM-Firmenich, a Swiss company listed on Euronext Amsterdam and SIX Swiss Exchange, announced on February 9, 2026, its intention to repurchase ordinary shares with an aggregate market value of €500 million to reduce its issued capital. Additionally, €40 million worth of shares were repurchased to cover commitments under the Group's share-based compensation plans, which was finalized on March 23, 2026. The company commenced repurchasing shares on March 12, 2026, for a total amount of €540 million. Weekly updates indicate ongoing progress, with 437,000 shares repurchased between June 1-5, 2026, for €30.0 million, and 184,000 shares between May 25-29, 2026, for €13.3 million. The €500 million program is expected to be completed by the end of Q3 2026.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard